STOCK TITAN

[Form 4] F5, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

F5, Inc. (FFIV) Form 4 summary — The reporting person, Schramm Lyra Amber, identified as Chief People Officer, reported a sale of 2,701 shares of F5 common stock on 09/08/2025 at a price of $316.57 per share. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan dated 06/09/2025. Following the reported disposition the filing shows 0 shares beneficially owned. The Form 4 was signed by Angelique M. Okeke by power of attorney on 09/09/2025. This disclosure records an officer-initiated sale under a pre-established plan; no additional financial results, forward guidance, or other transactions are included in this filing.

F5, Inc. (FFIV) Riepilogo del Modulo 4 — La persona che ha presentato la segnalazione, Schramm Lyra Amber, identificata come Chief People Officer, ha dichiarato la vendita di 2.701 azioni ordinarie F5 il 09/08/2025 al prezzo di $316,57 per azione. La comunicazione indica che la transazione è stata effettuata ai sensi di un piano di negoziazione Rule 10b5-1 datato 09/06/2025. Dopo la disposizione segnalata il documento mostra la detenzione beneficiaria di 0 azioni. Il Modulo 4 è stato firmato da Angelique M. Okeke per procura il 09/09/2025. Questa divulgazione documenta una vendita iniziata da un dirigente nell'ambito di un piano predefinito; non sono inclusi ulteriori risultati finanziari, guidance prospettiche o altre transazioni.

F5, Inc. (FFIV) Resumen del Formulario 4 — La persona informante, Schramm Lyra Amber, identificada como Chief People Officer, reportó la venta de 2.701 acciones ordinarias de F5 el 08/09/2025 a un precio de $316,57 por acción. La presentación indica que la transacción se ejecutó conforme a un plan de negociación Rule 10b5-1 fechado el 09/06/2025. Tras la enajenación informada, el documento muestra 0 acciones de propiedad beneficiaria. El Formulario 4 fue firmado por Angelique M. Okeke por poder el 09/09/2025. Esta divulgación registra una venta iniciada por un directivo bajo un plan preestablecido; no se incluyen resultados financieros adicionales, previsiones ni otras transacciones.

F5, Inc. (FFIV) 양식 4 요약 — 신고인 Schramm Lyra Amber는 최고인사책임자(Chief People Officer)로서 2025-09-08에 F5 보통주 2,701주를 주당 $316.57에 매도했다고 보고했습니다. 제출서류에는 이 거래가 2025-06-09자 Rule 10b5-1 거래계획에 따라 실행되었다고 기재되어 있습니다. 보고된 처분 후 해당 서류에는 실질적 소유주(beneficial owner)로서 0주가 기재되어 있습니다. 양식 4는 대리권에 따라 Angelique M. Okeke가 2025-09-09에 서명했습니다. 이 공시는 사전 수립된 계획에 따른 임원에 의한 매도 건을 기록한 것으로, 추가 재무실적, 향후 전망 또는 다른 거래는 포함되어 있지 않습니다.

F5, Inc. (FFIV) Résumé du Formulaire 4 — La personne déclarante, Schramm Lyra Amber, identifiée comme Chief People Officer, a déclaré la vente de 2 701 actions ordinaires F5 le 08/09/2025 au prix de 316,57 $ par action. Le dépôt indique que la transaction a été effectuée conformément à un plan de négociation Rule 10b5-1 daté du 09/06/2025. Suite à la cession signalée, le dépôt fait état de 0 action détenue à titre bénéficiaire. Le Formulaire 4 a été signé par procuration par Angelique M. Okeke le 09/09/2025. Cette divulgation enregistre une vente initiée par un dirigeant dans le cadre d'un plan préétabli ; aucun résultat financier supplémentaire, indication prospective ou autre transaction n'est inclus.

F5, Inc. (FFIV) Formular 4 Zusammenfassung — Die meldende Person, Schramm Lyra Amber, ausgewiesen als Chief People Officer, meldete den Verkauf von 2.701 Stammaktien von F5 am 08.09.2025 zu einem Preis von $316,57 je Aktie. Die Einreichung gibt an, dass die Transaktion gemäß einem Rule 10b5-1-Handelsplan vom 09.06.2025 ausgeführt wurde. Nach der gemeldeten Veräußerung weist die Meldung einen wirtschaftlichen Bestand von 0 Aktien aus. Das Formular 4 wurde am 09.09.2025 von Angelique M. Okeke per Vollmacht unterschrieben. Diese Offenlegung dokumentiert einen vom Vorstand initiierten Verkauf im Rahmen eines vorab festgelegten Plans; weitere Finanzergebnisse, Prognosen oder andere Transaktionen sind nicht enthalten.

Positive
  • None.
Negative
  • Reported disposition of 2,701 shares at $316.57 per share on 09/08/2025, leaving 0 shares beneficially owned following the transaction

Insights

TL;DR: Officer sale of 2,701 shares executed under a Rule 10b5-1 plan; filing shows no remaining beneficial ownership.

The Form 4 documents a routine, pre-planned disposition by an executive officer rather than an opportunistic open-market trade. The sale size and price are explicitly stated: 2,701 shares at $316.57 each on 09/08/2025. Because the sale was made under a 10b5-1 plan dated 06/09/2025, it meets the filing's stated affirmative-defense conditions. From a numbers perspective, the filing reports 0 shares owned after the transaction. This is a disclosure event rather than an operational or financial development for the company.

TL;DR: Disclosure shows compliance with Rule 10b5-1 and timely Form 4 reporting; no governance changes reported.

The document confirms procedural compliance: the transaction is identified as executed pursuant to a Rule 10b5-1 trading plan and was reported on Form 4 with a signature executed by power of attorney. The reporting person is listed as an officer (Chief People Officer). The filing contains no information on leadership changes, board actions, or amendments to executive agreements. As a governance disclosure, it is routine and informational.

F5, Inc. (FFIV) Riepilogo del Modulo 4 — La persona che ha presentato la segnalazione, Schramm Lyra Amber, identificata come Chief People Officer, ha dichiarato la vendita di 2.701 azioni ordinarie F5 il 09/08/2025 al prezzo di $316,57 per azione. La comunicazione indica che la transazione è stata effettuata ai sensi di un piano di negoziazione Rule 10b5-1 datato 09/06/2025. Dopo la disposizione segnalata il documento mostra la detenzione beneficiaria di 0 azioni. Il Modulo 4 è stato firmato da Angelique M. Okeke per procura il 09/09/2025. Questa divulgazione documenta una vendita iniziata da un dirigente nell'ambito di un piano predefinito; non sono inclusi ulteriori risultati finanziari, guidance prospettiche o altre transazioni.

F5, Inc. (FFIV) Resumen del Formulario 4 — La persona informante, Schramm Lyra Amber, identificada como Chief People Officer, reportó la venta de 2.701 acciones ordinarias de F5 el 08/09/2025 a un precio de $316,57 por acción. La presentación indica que la transacción se ejecutó conforme a un plan de negociación Rule 10b5-1 fechado el 09/06/2025. Tras la enajenación informada, el documento muestra 0 acciones de propiedad beneficiaria. El Formulario 4 fue firmado por Angelique M. Okeke por poder el 09/09/2025. Esta divulgación registra una venta iniciada por un directivo bajo un plan preestablecido; no se incluyen resultados financieros adicionales, previsiones ni otras transacciones.

F5, Inc. (FFIV) 양식 4 요약 — 신고인 Schramm Lyra Amber는 최고인사책임자(Chief People Officer)로서 2025-09-08에 F5 보통주 2,701주를 주당 $316.57에 매도했다고 보고했습니다. 제출서류에는 이 거래가 2025-06-09자 Rule 10b5-1 거래계획에 따라 실행되었다고 기재되어 있습니다. 보고된 처분 후 해당 서류에는 실질적 소유주(beneficial owner)로서 0주가 기재되어 있습니다. 양식 4는 대리권에 따라 Angelique M. Okeke가 2025-09-09에 서명했습니다. 이 공시는 사전 수립된 계획에 따른 임원에 의한 매도 건을 기록한 것으로, 추가 재무실적, 향후 전망 또는 다른 거래는 포함되어 있지 않습니다.

F5, Inc. (FFIV) Résumé du Formulaire 4 — La personne déclarante, Schramm Lyra Amber, identifiée comme Chief People Officer, a déclaré la vente de 2 701 actions ordinaires F5 le 08/09/2025 au prix de 316,57 $ par action. Le dépôt indique que la transaction a été effectuée conformément à un plan de négociation Rule 10b5-1 daté du 09/06/2025. Suite à la cession signalée, le dépôt fait état de 0 action détenue à titre bénéficiaire. Le Formulaire 4 a été signé par procuration par Angelique M. Okeke le 09/09/2025. Cette divulgation enregistre une vente initiée par un dirigeant dans le cadre d'un plan préétabli ; aucun résultat financier supplémentaire, indication prospective ou autre transaction n'est inclus.

F5, Inc. (FFIV) Formular 4 Zusammenfassung — Die meldende Person, Schramm Lyra Amber, ausgewiesen als Chief People Officer, meldete den Verkauf von 2.701 Stammaktien von F5 am 08.09.2025 zu einem Preis von $316,57 je Aktie. Die Einreichung gibt an, dass die Transaktion gemäß einem Rule 10b5-1-Handelsplan vom 09.06.2025 ausgeführt wurde. Nach der gemeldeten Veräußerung weist die Meldung einen wirtschaftlichen Bestand von 0 Aktien aus. Das Formular 4 wurde am 09.09.2025 von Angelique M. Okeke per Vollmacht unterschrieben. Diese Offenlegung dokumentiert einen vom Vorstand initiierten Verkauf im Rahmen eines vorab festgelegten Plans; weitere Finanzergebnisse, Prognosen oder andere Transaktionen sind nicht enthalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SCHRAMM LYRA AMBER

(Last) (First) (Middle)
C/O F5, INC.
801 5TH AVE.

(Street)
SEATTLE WA 98104

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
F5, INC. [ FFIV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief People Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/08/2025 S 2,701(1) D $316.57 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 6/9/2025.
Remarks:
/s/ Angelique M. Okeke by Power of Attorney 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for F5 (FFIV) disclose on 09/08/2025?

The Form 4 discloses that Chief People Officer Schramm Lyra Amber sold 2,701 shares at $316.57 per share on 09/08/2025 under a Rule 10b5-1 plan.

Was the sale executed under a Rule 10b5-1 trading plan?

Yes. The filing states the transaction was executed pursuant to a Rule 10b5-1 trading plan dated 06/09/2025.

How many shares does the reporting person own after the reported transaction?

The Form 4 reports 0 shares beneficially owned following the reported disposition.

Who signed the Form 4 and when was it filed?

The Form 4 shows a signature by Angelique M. Okeke by power of attorney on 09/09/2025.

Does the filing report any other transactions or derivative holdings?

No. The Form 4 contains only the reported non-derivative disposition of common stock and includes no derivative transactions.
F5 INC

NASDAQ:FFIV

FFIV Rankings

FFIV Latest News

FFIV Latest SEC Filings

FFIV Stock Data

18.42B
57.09M
0.6%
100.29%
3.03%
Software - Infrastructure
Computer Communications Equipment
Link
United States
SEATTLE